These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5882127)

  • 1. Electroconvulsive therapy combined with Nialamide in treatment of depression.
    Misurec J; Jaros M
    Act Nerv Super (Praha); 1965 Aug; 7(3):293-4. PubMed ID: 5882127
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of depressive states with infusions of Nialamide.
    Misurec J; Bojanovský J; Chloupková K
    Act Nerv Super (Praha); 1965 Aug; 7(3):294-5. PubMed ID: 5883125
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of depressive conditions using nialamide infusions].
    Misurec J; Bojanovský J; Chloupková K
    Cesk Psychiatr; 1966 Apr; 62(2):114-8. PubMed ID: 5930847
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electroconvulsive therapy in the treatment of chronic depression].
    Reisner H
    Wien Med Wochenschr; 1971 Jul; 121(27):560-3. PubMed ID: 5135459
    [No Abstract]   [Full Text] [Related]  

  • 5. The electroconvulsive treatment of depression.
    Wengert JW; Egger M
    Nebr Med J; 1975 Nov; 60(11):449-52. PubMed ID: 1186941
    [No Abstract]   [Full Text] [Related]  

  • 6. The action of antidepressants and convulsive treatment upon the higher nervous activity in depressive states.
    Saarma J; Saarma M
    Cond Reflex; 1973; 8(1):57-60. PubMed ID: 4714916
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nialamide as a major antidepressive and anxiolytic agent].
    Dubois JC; Dacharry JC; Demoures JM
    J Med Bord; 1967 Oct; 144(10):1536-43. PubMed ID: 5605728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of neuropton (nialamide-hydroxyzine pamoate)].
    Bourgeois M
    Ann Med Psychol (Paris); 1970 Jan; 1(1):134-8. PubMed ID: 5421306
    [No Abstract]   [Full Text] [Related]  

  • 9. Electroconvulsive therapy in patients with cavernous hemangiomas.
    Rasmussen KG; Flemming KD
    J ECT; 2006 Dec; 22(4):272-3. PubMed ID: 17143161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epontol in electroconvulsive therapy].
    Beckman M; Gruvstad M; Ribacke M
    Nord Med; 1971 Feb; 85(7):202-5. PubMed ID: 5547123
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple monitored electroconvulsive treatment.
    Goldfarb C; Goldfarb S
    Curr Psychiatr Ther; 1977; 17():275-81. PubMed ID: 598237
    [No Abstract]   [Full Text] [Related]  

  • 12. [On high-dosage parenteral niamid treatment of depressive syndromes].
    Cornu F; Hodel J
    Nervenarzt; 1965 Dec; 36(12):515-8. PubMed ID: 5334474
    [No Abstract]   [Full Text] [Related]  

  • 13. A critical look at antidepressant drug trials.
    Leyburn P
    Lancet; 1967 Nov; 2(7526):1135-8. PubMed ID: 4168568
    [No Abstract]   [Full Text] [Related]  

  • 14. Bitemporal electroconvulsive therapy for depression in a Parkinson disease patient with a deep-brain stimulator.
    Bailine S; Kremen N; Kohen I; Linder H; Schwartz GJ; Mogilner AY; Pourfar M
    J ECT; 2008 Jun; 24(2):171-2. PubMed ID: 18580566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of propanidid, a short-duration anesthetic in electroconvulsive therapy (420 cases)].
    Barale F; Longhini C; Egreteau JP; Allers G; Volmat R; Magnin P
    Anesth Analg (Paris); 1970; 27(2):331-7. PubMed ID: 5421676
    [No Abstract]   [Full Text] [Related]  

  • 16. Cognitive tolerability of electroconvulsive therapy in a patient with a history of traumatic brain injury.
    Martino C; Krysko M; Petrides G; Tobias KG; Kellner CH
    J ECT; 2008 Mar; 24(1):92-5. PubMed ID: 18379342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of treatment procedures upon memory functions in depressive states.
    Saarma J; Saarma M
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():373-4. PubMed ID: 551668
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychoendocrine aspects of depression and ECT.
    Clower CG; Migeon CJ
    Johns Hopkins Med J; 1967 Oct; 121(4):227-33. PubMed ID: 6062088
    [No Abstract]   [Full Text] [Related]  

  • 19. Memory change following EST and drug treated depression.
    Templer DI; Penick SB; Buonpane N
    J Med Soc N J; 1973 Jun; 70(6):453-4. PubMed ID: 4514622
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen: a case study and cost analysis.
    Warnell RL; Elahi N
    J ECT; 2007 Jun; 23(2):114-9. PubMed ID: 17548984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.